The RAO market is projected to reach $15.8B by 2035, driven by global regulatory complexity, cost efficiency needs, and ...

Martin Kesselgruber, VP Head of Global Project Management at Bachem, offers insights on the key measures for companies to ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

We are excited to welcome the talented team at Regulus to Novartis as we continue to build on our pipeline in renal disease with high unmet medical need.” Farabursen is an investigational ...

U.S. exchange operators are in talks with the Securities and Exchanges Commission on easing regulatory burdens for public ...

The designation reinforces the potential of QRX003 as a therapeutic candidate for a profoundly underserved pediatric population. It follows earlier regulatory recognition by the European Medicines ...

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced an updated timeline for submitting its Biologics ...

In this Prominent People in Packaging interview, Aladin Alkhawam discusses the challenges and intricacies of implementing the ...

Enhance your pharmacovigilance operations with our comprehensive training course tailored for pharmaceutical and biologic companies. Gain insights into US, EU, and UK drug safety regulatory ...